The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Urges Innovators to produce quality products that can be deployed at scale
Construction will begin this year with the new capacity anticipated by 2025
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
India’s efforts are aimed at boosting health at the last mile
Subscribe To Our Newsletter & Stay Updated